We are live on ! Find out more
Jane Street

Jane Street Portfolio holdings

AUM $777B
1-Year Est. Return 61.18%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Fund
S&P 500
This Quarter Est. Return
+7.45%
1 Year Est. Return
+61.18%
3 Year Est. Return
+147.64%
5 Year Est. Return
+157.48%
10 Year Est. Return
+673.77%
AUM
$256B
AUM Growth
+$54.4B
Cap. Flow
+$36.7B
Cap. Flow %
14.37%
Top 10 Hldgs %
36.58%
Holding
10,953
New
1,924
Increased
4,219
Reduced
3,459
Closed
1,267

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 2.5%
2 Technology 2.1%
3 Healthcare 1.18%
4 Financials 0.9%
5 Industrials 0.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PKBOW
9626
DELISTED
Peak Bio, Inc. Warrant
PKBOW
$19K ﹤0.01%
25,050
+50
+0.2% +$38
FCAX.WS
9627
DELISTED
Fortress Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
FCAX.WS
$19K ﹤0.01%
17,862
+7,842
+78% +$7.86K
KWAC.WS
9628
DELISTED
Kingswood Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common
KWAC.WS
$19K ﹤0.01%
27,519
-61
-0.2% -$36
BCTXW
9629
DELISTED
BriaCell Therapeutics Corp Warrant
BCTXW
$18K ﹤0.01%
+10,181
New +$12.7K
BTOG icon
9630
Bit Origin
BTOG
$2.14M
$18K ﹤0.01%
+6
New +$12.6K
TLSIW icon
9631
TriSalus Life Sciences Warrant
TLSIW
$29M
$18K ﹤0.01%
17,860
-740
-4% -$730
BRQS
9632
DELISTED
Borqs Technologies, Inc. Ordinary Shares
BRQS
$18K ﹤0.01%
63
-6
-9% -$1.18K
CHGA
9633
Change Agents Corporation Common Stock
CHGA
$2.66M
$17K ﹤0.01%
+117
New +$18.7K
CCVI.WS
9634
DELISTED
Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCVI.WS
$17K ﹤0.01%
+12,108
New +$16.3K
SCOBW
9635
DELISTED
ScION Tech Growth II Warrants
SCOBW
$17K ﹤0.01%
+17,919
New +$13.7K
NSTC.WS
9636
DELISTED
Northern Star Investment Corp. III Redeemable Warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTC.WS
$17K ﹤0.01%
+13,700
New +$14.7K
IMNN icon
9637
Imunon
IMNN
$6.64M
$16K ﹤0.01%
65
-33
-34% -$7.8K
SWBK.WS
9638
DELISTED
Switchback II Corporation Warrants, exercisable for one share of Class A Ordinary Share
SWBK.WS
$16K ﹤0.01%
11,424
-9,554
-46% -$14.2K
ACGN
9639
DELISTED
Aceragen Inc
ACGN
$15K ﹤0.01%
+766
New +$15.4K
NMTR
9640
PUT
DELISTED
9 Meters Biopharma
NMTR
$15K ﹤0.01%
+685
New +$16.8K
FOXWW
9641
DELISTED
FoxWayne Enterprises Acquisition Corp. Warrant
FOXWW
$15K ﹤0.01%
22,814
-677
-3% -$351
VTIQW
9642
DELISTED
VectoIQ Acquisition Corp. II Warrant
VTIQW
$15K ﹤0.01%
10,782
+339
+3% +$428
ZWRKW
9643
DELISTED
Z-Work Acquisition Corp. Warrant
ZWRKW
$15K ﹤0.01%
16,600
PRSTW
9644
DELISTED
Presto Technologies, Inc. Warrant
PRSTW
$14K ﹤0.01%
+37,703
New +$15.5K
ATA.WS
9645
DELISTED
Americas Technology Acquisition Corp.Redeemable Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50
ATA.WS
$14K ﹤0.01%
21,018
+352
+2% +$200
TNXP icon
9646
Tonix Pharmaceuticals
TNXP
$181M
0
DMK
9647
PUT
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$13K ﹤0.01%
163
-74
-31% -$4.51K
KLAQW
9648
DELISTED
KL Acquisition Corp Warrant
KLAQW
$13K ﹤0.01%
13,821
+421
+3% +$339
CRVO icon
9649
CervoMed
CRVO
$26.9M
$12K ﹤0.01%
+214
New +$11.8K
GLEO.WS
9650
DELISTED
Galileo Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Ordinary Share
GLEO.WS
$12K ﹤0.01%
+10,652
New +$10.5K

Similar funds

Jane Street's Q2 2021 Portfolio in Review

As of Q2 2021, Jane Street held 10,953 positions worth $256B, up 27% from $201B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Jane Street deployed $36.7B of net new capital in Q2 2021, opening 1,924 new positions and adding to 4,219 existing holdings. Its largest new stake was iShares MSCI EAFE ETF: 6,071,963 shares worth $479M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 2.5% of assets, down from 2.8% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Baidu, an estimated $964M trimmed.

  • Jane Street's largest Q2 2021 buy was iShares MSCI EAFE ETF: 6,071,963 shares worth $479M.
  • Jane Street added most to iShares MBS ETF in Q2 2021, an estimated $629M increase.
  • Jane Street's biggest Q2 2021 reduction was Baidu, cutting an estimated $964M.
  • Jane Street fully exited Invesco Senior Loan ETF in Q2 2021, selling an estimated $369M.
  • Jane Street's ten largest holdings make up 37% of its $256B portfolio in Q2 2021.
  • Jane Street opened 1,924 new positions and closed 1,267 in Q2 2021.
  • Jane Street's portfolio value rose 27% quarter-over-quarter to $256B.

Based on Jane Street's 13F filing for Q2 2021, filed 16 Aug 2021.